Chinese drug developer Sinovac raises $86.73 in private placement

China-based drug developer Sinovac Biotech has closed $86.73 million in a private placement. The investors were Vivo Capital and Advantech Capital. Houlihan Lokey served as financial adviser to Sinovac on the transaction.

DealsNorth AmericaUSHealthcareBriefs